A Polypill for Acute Coronary Syndrome

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.

Also called NCT07032389

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07032389
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07032389. Randomized; no masking; primary purpose treatment. Start 2025-12-05 (actual); primary completion 2030-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Polypill for Acute Coronary Syndrome
Acronym
PolyACS
Condition
Acute Coronary Syndrome
Intervention (Combination product)
Polypill
Lead sponsor
University of Texas Southwestern Medical Center (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct07032389
Content hash
2c5068bcab5ae41145cc725c9811b1f9ffa6fd94631654ad7da2f0b650d91414